Prognosis and influencing factors of ER-positive, HER2-low breast cancer patients with residual disease after neoadjuvant chemotherapy: a retrospective study

Lingfeng Tang(Xi'an Jiaotong University), Shengchun Liu(The Affiliated Yongchuan Hospital of Chongqing Medical University), Xiujie Shu(The Affiliated Yongchuan Hospital of Chongqing Medical University), Haochen Yu(St. Michael's Hospital), Yudi Jin(Dalian Medical University), Linshan Jiang(The Affiliated Yongchuan Hospital of Chongqing Medical University)
Scientific Reports
May 23, 2024
10.1038/s41598-024-62592-0
Cited by 2

Related Papers

Increased NF-κB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer's disease
|The International Journal of Neuropsychopharmacology|2011|430
Sulfasalazine‑induced ferroptosis in breast cancer cells is reduced by the inhibitory effect of estrogen receptor on the transferrin receptor
|Oncology Reports|2019|223
Diagnostic Value of Circulating Chromogranin A for Neuroendocrine Tumors: A Systematic Review and Meta-Analysis
|PLoS ONE|2015|101
CXCL1 stimulates migration and invasion in ER‑negative breast cancer cells via activation of the ERK/MMP2/9 signaling axis
|International Journal of Oncology|2019|77
Assessment of the predictive role of pretreatment Ki-67 and Ki-67 changes in breast cancer patients receiving neoadjuvant chemotherapy according to the molecular classification: a retrospective study of 1010 patients
|Breast Cancer Research and Treatment|2018|74